Muriel, from the Auxiliary of Social Life, works at the home of Mr. T, who has multiple sclerosis, in Pas de Calais, France, on June 11, 2023. (Astier / BSIP via AFP) (CN) — For people living with ...

Throughout the year, Teva had momentum in innovative medicines, scaling its global generics and biosimilars portfolio. On the brand side, Teva said it continued to showcase strong performance of its ...

Teva Pharmaceutical is one of the leading global generic drug manufacturers. By our estimate, roughly 70% of its total revenue is derived from generics and off-patent branded drugs. Generic drugs in ...

Out Of Order is a Java-based interactive game designed to test and improve the player's cognitive abilities. In this game, players are presented with a sequence of characters or numbers that are out ...

Teva Pharmaceutical Industries Limited has successfully shifted its strategy, leveraging its generics business to fund growth in specialty medicines, driving a turnaround in performance. TEVA's "Pivot ...

Monday - Friday, 11:00 - 12:00 SIN/HK | 0500 - 06:00 CET Shreehas Tambe, CEO & managing director of Biocon Biologics, discusses the way that US tariff & manufacturing policy affects India's ...

A new analysis has raised concerns about the Cigna Group’s drug pricing strategy, finding that one of its subsidiaries, Quallent Pharmaceuticals, often charges more for generic medications than ...

President Donald Trump’s top health advisers announced a push to cut health costs by bringing more cutting-edge generic drugs to market in a press conference on Wednesday. The Food and Drug ...

CEO Narasimhan says no tariff impact on guidance Top-selling heart drug Entresto sees growth stall Older drugs hit by 'generic erosion' in US market Newer drugs help offset some of the slowdown ...

FRANKFURT (Reuters) -Novartis' blockbuster heart treatment Entresto saw sales growth stall in the third quarter of the year, dragging the Swiss company's shares lower, as its top-selling drug comes ...